Exchange: NYSEMkt·Updated 07:47 AM EDT
CLDI logo

CLDI Calidi Biotherapeutics Inc - Ordinary Shares - Class A

$1.37
$0.015
(1.08%)
Pre-Market
Prev Close $1.39
Mkt Cap$3.58M
Vol8,341.00

About CLDI

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
52

Neutral Sentiment

How do you feel about CLDI?

Advertisement|Remove ads.